Clinical Cardiology

Article	Citations
Cardiovascular manifestations in severe and critical patients with COVID‐19	70
The potential association between common comorbidities and severity and mortality of coronavirus disease 2019: A pooled analysis	54
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID‐19, inflammation level, severity, and death in patients with	46
“Missing” acute coronary syndrome hospitalizations during the COVID‐19 era in Greece: Medical care avoidance combined with a true reduction in incidence?	43
COVID‐19, thromboembolic risk, and Virchow's triad: Lesson from the past	42
Remarkable response to cardiac resynchronization therapy via left bundle branch pacing in patients with true left bundle branch block	41
Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C stu	39
COVID‐19 and the heart: An update for clinicians	39
Role of wearable rhythm recordings in clinical decision making—The wEHRAbles project	36
On‐demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation	34
Cardiac amyloidosis‐A review of current literature for the practicing physician	31
Predicting 90 day acute heart failure readmission and death using machine learning‐supported decision analysis	26
A novel machine learning algorithm, Bayesian networks model, to predict the high‐risk patients with cardiac surgery‐associated acute kidney injury	26
Cardiovascular safety of febuxostat compared to allopurinol for the treatment of gout: A systematic and meta‐analysis	25
Risk factors and electrocardiogram characteristics for mortality in critical inpatients with COVID‐19	25
Atherogenic index of plasma and the risk of advanced subclinical coronary artery disease beyond traditional risk factors: An observational cohort study	24
Gender differences in acute myocardial infarction—A nationwide German real‐life analysis from 2014 to 2017	24
Infective endocarditis complicated by embolic events: Pathogenesis and predictors	23
Clinical outcomes of left bundle branch pacing compared to right ventricular apical pacing in patients with atrioventricular block	23
Importance of epicardial adipose tissue localization using cardiac magnetic resonance imaging in patients with heart failure with mid‐range and preserved ejection fraction	22
Machine learning for early prediction of in‐hospital cardiac arrest in patients with acute coronary syndromes	21
Assessment of ventricular mechanical synchronization after left bundle branch pacing using 2‐D speckle tracking echocardiography	21
Comparison of high‐power short‐duration and low‐power long‐duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta‐analysis	21
Efficacy and safety of same‐day discharge after atrial fibrillation ablation: A systematic review and meta‐analysis	21
Anxiety and prognosis of patients with myocardial infarction: A meta‐analysis	20

Risk stratification of cardiac arrhythmias and sudden cardiac death in type 2 diabetes mellitus patients receiving insulin therapy: A population‐based cohort study	19
The adolescent athlete's heart; A miniature adult or grown‐up child?	19
Expression of miRNAs in plasma exosomes derived from patients with atrial fibrillation	19
Prevalence and impact of cardiac injury on COVID‐19: A systematic review and meta‐analysis	19
The cardiovascular outcomes, heart failure and kidney disease trials tell that the time to use Sodium Glucose Cotransporter 2 inhibitors is now	19
Comparative effects of left bundle branch area pacing, His bundle pacing, biventricular pacing in patients requiring cardiac resynchronization therapy: A network meta‐analysis	19
Kidney outcomes using a sustained ≥40% decline in eGFR: A meta‐analysis of SGLT2 inhibitor trials	19
A novel study on SARS‐COV‐2 virus associated bradycardia as a predictor of mortality‐retrospective multicenter analysis	18
Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multination	18
Comparison of coronary atherosclerotic disease burden between ST‐elevation myocardial infarction and non‐ST‐elevation myocardial infarction: Non‐culprit Gensini score	18
Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease	17
Lipid levels and risk of new‐onset atrial fibrillation: A systematic review and dose‐response meta‐analysis	17
Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure	17
Mortality and guideline‐directed medical therapy in real‐world heart failure patients with reduced ejection fraction	17
Chronic biopsy proven post‐COVID myoendocarditis with SARS‐Cov‐2 persistence and high level of antiheart antibodies	17
Characteristics and long‐term prognosis of patients with reduced, mid‐range, and preserved ejection fraction: A systemic review and meta‐analysis	17
Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in Alberta, Canada: A real‐world evidence study	16
Hospitalization deficit of in‐ and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID‐19 pandemic: Insights from the German‐wide h	16
Myocarditis after COVID‐19 mRNA vaccination: A systematic review of case reports and case series	16
Invasive therapy versus conservative therapy for patients with stable coronary artery disease: An updated meta‐analysis	16
Hyperkalemia in heart failure: Foe or friend?	15
A randomized controlled clinical trial of cardiac telerehabilitation with a prolonged mobile care monitoring strategy after an acute coronary syndrome	14
Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta‐analysis and systematic review	14
Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation	14
Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta‐analysis	14
Novel doses of sacubitril/valsartan in patients unable to tolerate traditional therapy: Effects on N‐terminal pro B‐type natriuretic peptide levels	14
Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry	14
Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans	14
Natural language processing for the assessment of cardiovascular disease comorbidities: The cardio‐Canary comorbidity project	13
Necklace‐embedded electrocardiogram for the detection and diagnosis of atrial fibrillation	13
Communication approaches to enhance patient motivation and adherence in cardiovascular disease prevention	13
The efficacy of mobile health in alleviating risk factors related to the occurrence and development of coronary heart disease: A systematic review and meta‐analysis	13
Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score	13
Effect of non‐recommended doses versus recommended doses of direct oral anticoagulants in atrial fibrillation patients: A meta‐analysis	13
Fluoroscopy usage in contemporary interventional electrophysiology: Insights from a European registry	13
Efficacy and safety of early initiation of Sacubitril/Valsartan in patients after acute myocardial infarction: A meta‐analysis	12
Point‐of‐care ultrasound: Closing guideline gaps in screening for valvular heart disease	12
Association between right ventricular dysfunction and mortality in COVID‐19 patients: A systematic review and meta‐analysis	12
Effects of rivaroxaban and warfarin on the risk of gastrointestinal bleeding and intracranial hemorrhage in patients with atrial fibrillation: Systematic review and meta‐analysis	12
Combined effects of carotid plaques and hypertension on the risk of cardiovascular disease and all‐cause mortality	12
The efficacy and safety of left atrial low‐voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial: Desi	12
The safety of morphine in patients with acute heart failure: A systematic review and meta‐analysis	12
Influence of seasons on the management and outcomes acute myocardial infarction: An 18‐year US study	12
Plasma catecholamine levels in the acute and subacute stages of takotsubo syndrome: Results from the Stockholm myocardial infarction with normal coronaries 2 study	12
Rationale and design of the precise percutaneous coronary intervention plan (P3) study: Prospective evaluation of a virtual computed tomography‐based percutaneous intervention planner	12
New‐onset atrial fibrillation and outcomes following isolated coronary artery bypass surgery: A systematic review and meta‐analysis	12
Clinical relevance of serum uric acid and abdominal aortic‐calcification in a national survey	11
N‐terminal pro‐brain natriuretic peptide and short‐term mortality in acute aortic dissection: A meta‐analysis	11
The prognostic significance of electrocardiography findings in patients with coronavirus disease 2019: A retrospective study	11
Statin use in patients with non‐HMGCR idiopathic inflammatory myopathies: A retrospective study	11

Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: “Real‐world” evidence	11
The predictive value of a concise classification of left atrial appendage morphology to thrombosis in non‐valvular atrial fibrillation patients	11
Bioprosthetic vs mechanical mitral valve replacement for infective endocarditis in patients aged 50 to 69 years	11
Percutaneous edge‐to‐edge repair of severe mitral regurgitation using the MitraClip XTR versus NTR system	11
The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta‐analysis on the obesity paradox	11
Myocardial infarction classification and its implications on measures of cardiovascular outcomes, quality, and racial/ethnic disparities	11
General anesthesia is not superior to sedation in clinical outcome and cost‐effectiveness for ablation of persistent atrial fibrillation	11
Obstructive sleep apnea therapy for cardiovascular risk reduction—Time for a rethink?	11
ACC.20: Impact of social media at the virtual scientific sessions during the COVID‐19 pandemic	10
Feasibility and stability of left bundle branch pacing in patients after prosthetic valve implantation	10
Anxiety is associated with higher recurrence of atrial fibrillation after catheter ablation: A meta‐analysis	10
Prognostic implications of biventricular strain measurement in COVID‐19 patients by speckle‐tracking echocardiography	10
Neutrophil/lymphocyte ratio predicts in‐hospital complications in Takotsubo syndrome. Results from a prospective multi‐center registry	10
Diagnosis and treatment of transthyretin‐related amyloidosis cardiomyopathy	10
Utilization and in‐hospital complications of catheter ablation for atrial fibrillation in patients with obesity and morbid obesity	10
Cardio‐ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients	10
Impact of the new pulmonary hypertension definition on long‐term mortality in patients with severe aortic stenosis undergoing valve replacement	10
Is race or ethnicity associated with under‐utilization of statins among women in the United States: The study of women's health across the nation	10
NT Pro‐BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement	10
Exercise: The ultimate treatment to all ailments?	10
Conventional cardiovascular risk factors associated with Takotsubo cardiomyopathy: A comprehensive review	10
Lipid goal attainment in post‐acute coronary syndrome patients in China: Results from the 6‐month real‐world dyslipidemia international study II	9
Outcomes of percutaneous coronary intervention for chronic total occlusions in the elderly: A systematic review and meta‐analysis	9
Applicability of the REDUCE‐IT trial to the FAST‐MI registry. Are the results of randomized trials relevant in routine clinical practice?	9
Prognostic value of aerobic capacity and exercise oxygen pulse in postaortic dissection patients	9
The role of transesophageal echocardiography in predicting technical problems and complications of transvenous lead extractions procedures	9
Association between anxiety and clinical outcomes in Chinese patients with myocardial infarction in the absence of obstructive coronary artery disease	9
Sex‐gender disparities in nonagenarians with acute coronary syndrome	9
Ultrafiltration and cardiopulmonary bypass associated acute kidney injury: A systematic review and meta‐analysis	9
Reduced cardiac function is associated with cardiac injury and mortality risk in hospitalized COVID‐19 Patients	9
Cardiac rehabilitation: Effective yet underutilized in patients with cardiovascular disease	9
Clinical implication of quantitative flow ratio to predict clinical events after drug‐coated balloon angioplasty in patients with in‐stent restenosis	9
Association between the platelet‐lymphocyte ratio and short‐term mortality in patients with non‐ST‐segment elevation myocardial infarction	8
Immediate and early percutaneous coronary intervention in very high‐risk and high‐risk non‐ST segment elevation myocardial infarction patients	8
Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States	8
Cardiovascular event rate and death in high‐risk secondary prevention patient cohort in Finland: A registry study	8
Safety of ACEi and ARB in COVID‐19 management: A retrospective analysis	8
Clinical impact of complete atrioventricular block in patients with ST‐segment elevation myocardial infarction	8
Association of premature ventricular complexes and risk of ischemic stroke: A systematic review and meta‐analysis	8
Sudden cardiac death in HIV‐infected patients: A contemporary review	8
Ethnic differences in quality of life and its association with survival in patients with heart failure	8
Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction	8
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta‐analysis	8
Long‐term outcomes of patients undergoing coronary sinus reducer implantation ‐ A multicenter study	8
QTc interval evaluation in patients with right bundle branch block or bifascicular blocks	8
Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure	8
Left atrial stiffness in women with ischemia and no obstructive coronary artery disease: Novel insight from left atrial feature tracking	8
Zero‐fluoroscopy transseptal puncture guided by right atrial electroanatomical mapping combined with intracardiac echocardiography: A single‐center experience	8
Predictive value of the age, creatinine, and ejection fraction score in patients with myocardial infarction with nonobstructive coronary arteries	8
Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe—Rationale and design of the international BENCHMARK	8
Comparison of six assessment tools to screen for obstructive sleep apnea in patients with hypertension	8
Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID‐19	8
Atrial fibrillation catheter ablation complications in obese and diabetic patients: Insights from the US Nationwide Inpatient Sample 2005–2013	8
Correlation analysis of the triglyceride glucose index and heart failure with preserved ejection fraction in essential hypertensive patients	8
Decongestive treatment adjustments in heart failure patients remotely monitored with a multiparametric implantable defibrillators algorithm	8
Effect of electrical cardioversion on 1‐year outcomes in patients with early recurrence after catheter ablation for atrial fibrillation	8
Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy	7
Safety and efficacy of left atrial appendage occlusion with the ACP or Watchman device guided by intracardiac echocardiography from the left atrium	7
Clinical value of pulmonary congestion detection by lung ultrasound in patients with chronic heart failure	7
Review paper on WPW and athletes: Let sleeping dogs lie?	7
Prevalence of atrial fibrillation dependent on coronary artery status: Insights from the LIFE‐Heart Study	7
Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta‐analysis of adjusted observational studies	7
Cardiovascular manifestations in severe and critical patients with COVID‐19	7
Clinical and prognostic implications of C‐reactive protein levels in myocardial infarction with nonobstructive coronary arteries	7
Risk and predictors of dyssynchrony cardiomyopathy in left bundle branch block with preserved left ventricular ejection fraction	7
Development of an optimized risk score to predict short‐term death among acute myocardial infarction patients in rural China	7
Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study	7
Outcomes of ST‐elevation myocardial infarction by age and sex in a low‐income urban community: The Montefiore STEMI Registry	7
A predictive model using left atrial function and B‐type natriuretic peptide level in predicting the recurrence of early persistent atrial fibrillation after radiofrequency ablation	7
Early identification and treatment of women's cardiovascular risk factors prevents cardiovascular disease, saves lives, and protects future generations: Policy recommendations and take action plan uti	7
Genetics, its role in preventing the pandemic of coronary artery disease	7
Does continuous positive airway pressure therapy benefit patients with coronary artery disease and obstructive sleep apnea? A systematic review and meta‐analysis	7
Electrocardiographic parameters and prognosis of renal light chain amyloidosis	7
Ventricular repolarization heterogeneity in patients with COVID‐19: Original data, systematic review, and meta‐analysis	7
Association of muscular fitness with rehospitalization for heart failure with reduced ejection fraction	7
Predictive value of the atherogenic index of plasma for chronic total occlusion before coronary angiography	7
Impact of body mass index on procedural complications, procedure duration, and radiation dose in patients with atrial fibrillation undergoing radiofrequency ablation: A systematic review and meta‐anal	7
The relationship between the body mass index and in‐hospital mortality in patients admitted for sudden cardiac death in the United States	7
Restrictive vs liberal red blood cell transfusion strategies in patients with acute myocardial infarction and anemia: Rationale and design of the REALITY trial	6
Influence of coronary artery disease and percutaneous coronary intervention on mid‐term outcomes in patients with aortic valve stenosis treated with transcatheter aortic valve implantation	6

Effects of clopidogrel, prasugrel and ticagrelor on prevention of stent thrombosis in patients underwent percutaneous coronary intervention: A network meta‐analysis	6
Comparative effects of intensive ganglionated plexus ablation in treating paroxysmal atrial fibrillation and vasovagal syncope	6
Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention	6
Epidemiological characteristics, management, and outcomes of atrial fibrillation in TUNISIA: Results from the National Tunisian Registry of Atrial Fibrillation (NATURE‐AF)	6
Intracardiac versus transesophageal echocardiography for diagnosis of left atrial appendage thrombosis in atrial fibrillation: A meta‐analysis	6
Association between bicuspid aortic valve phenotype and patterns of valvular dysfunction: A meta‐analysis	6
Comparison among random forest, logistic regression, and existing clinical risk scores for predicting outcomes in patients with atrial fibrillation: A report from the J‐RHYTHM registry	6
Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES‐based cohort study	6
Management of LDL‐cholesterol after an acute coronary syndrome: Key comparisons of the American and European clinical guidelines to the attention of the healthcare providers	6
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry	6
Management of arterial hypertension: Challenges and opportunities	6
Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris	6
Isolated diastolic hypertension and target organ damage: Findings from the STANISLAS cohort	6
Effectiveness of proprotein convertase subtilisin/kexin‐9 monoclonal antibody treatment on plasma lipoprotein(a) concentrations in patients with elevated lipoprotein(a) attending a clinic	6
Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double‐blinded clinical trial	6
Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator	6
Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from theATHENAstudy	6
Insights into foundational therapies for heart failure with reduced ejection fraction	6
The optimal cutoff of atrial high‐rate episodes for neurological events in patients with dual chamber permanent pacemakers	6
Cost‐minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications	6
Resynchronization effects and clinical outcomes during left bundle branch area pacing with and without conduction system capture	6
Metabolic syndrome and concomitant diabetes mellitus are associated with higher risk of cardiovascular comorbidity in patients with primary glomerular diseases: A retrospective observational study	6
Association between insomnia and the incidence of myocardial infarction: A systematic review and meta‐analysis	6
Significant decrease in plasmad‐dimer levels and mean platelet volume after a 3‐month treatment with rosuvastatin in patients with venous thromboembolism	6
First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardio	6
Evaluation of electrophysiological characteristics and ventricular synchrony: An intrapatient‐controlled study during His‐Purkinje conduction system pacing versus right ventricular pacing	6
Non‐vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta‐analysis of obse	6
Procedural outcomes and learning curve of cardiac arrhythmias catheter ablation using remote magnetic navigation: Experience from a large‐scale single‐center study	6
N‐terminal pro‐B‐type natriuretic peptide and D‐dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation	5
Effect of obstructive sleep apnea on right ventricular ejection fraction in patients with hypertrophic obstructive cardiomyopathy	5
Performance of the coronary calcium score in an outpatient chest pain clinic and strategies for risk stratification	5
Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study	5
Mechanical or biologic prostheses for mitral valve replacement: A systematic review and meta‐analysis	5
Sleep‐disordered breathing in heart failure patients with different etiologies	5
Melatonin supplementation improves N‐terminal pro‐B‐type natriuretic peptide levels and quality of life in patients with heart failure with reduced ejection fraction: Results from MeHR trial, a random	5
Off‐pump versus on‐pump coronary artery bypass grafting for octogenarians: A meta‐analysis involving 146 372 patients	5
Machine learning‐based prediction of 1‐year mortality in hypertensive patients undergoing coronary revascularization surgery	5
Birthweight predicts adult cardiovascular disorders: Population based cross sectional survey	5
Practical cardiovascular risk calculator for asymptomatic patients with type 2 diabetes mellitus: PRECISE‐DM risk score	5
Predictors of ventricular pacing burden after permanent pacemaker implantation following transcatheter aortic valve replacement	5
Distinguishing exercise intolerance in early‐stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE/VCO2 and ETCO2 identify pulmonary	5
Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study‐level meta‐	5
Association between severity of obstructive sleep apnea and high‐sensitivity C‐reactive protein in patients with hypertrophic obstructive cardiomyopathy	5
Development of myocarditis and pericarditis after COVID‐19 vaccination in children and adolescents: A systematic review	5
Association between visceral adiposity index and heart failure: A cross‐sectional study	5
Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator	5
Cardiac computed tomography angiography‐derived analysis of left atrial appendage morphology and left atrial dimensions for the prediction of atrial fibrillation recurrence after pulmonary vein isolat	5
State‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy	5
Tailored risk assessment of 90‐day acute heart failure readmission or all‐cause death to heart failure with preserved versus reduced ejection fraction	5
Association of lipoprotein(a) with aortic dissection	5
Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre‐treated with n	5
A deep neural network using audio files for detection of aortic stenosis	5
Transcatheter vs surgical aortic valve replacement in low to intermediate surgical risk aortic stenosis patients: A systematic review and meta‐analysis of randomized controlled trials	5
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A systematic review and meta‐analysis	5
Long‐term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2‐year observations from the EPICOR Asia study	5
Association between brachial‐ankle pulse wave velocity and cardiovascular and cerebrovascular disease in different age groups	5
Effects of COPD on in‐hospital outcomes of transcatheter aortic valve implantation: Results from the National Inpatient Sample database	5
Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis	5
Dual‐center experiences with interventional closure of patent foramen ovale: A medium‐term follow‐up study comparing two patient groups aged under and over 60 years	5
The prognostic impact of left ventricular thrombus resolution after acute coronary syndrome and risk modulation via antithrombotic treatment strategies	5
New strategies and therapies for the prevention of heart failure in high‐risk patients	5
A remote hypertension management program clinical algorithm	5
Comparison between the double‐syringe and the single‐syringe techniques of adenosine administration for terminating supraventricular tachycardia: A pilot, randomized controlled trial	5
Effects of resistance exercise on treatment outcome and laboratory parameters of Takayasu arteritis with magnetic resonance imaging diagnosis: A randomized parallel controlled clinical trial	5
Differences in activated clotting time and total unfractionated heparin dose during pulmonary vein isolation in patients on different anticoagulation therapy	5
Development a clinical prediction model of the neurological outcome for patients with coma and survived 24 hours after cardiopulmonary resuscitation	5
Ten‐year clinical outcomes in patients with intermediate coronary stenosis according to the combined culprit lesion	5
Platelet‐to‐lymphocyte ratio a potential prognosticator in acute myocardial infarction: A prospective longitudinal study	5
Repetitive milrinone therapy in ambulatory advanced heart failure patients	5
Pericardial fat volume and coronary atherosclerotic markers among body mass index groups	5
Acute cardiovascular hospitalizations and illness severity before and during the COVID‐19 pandemic	5
Evaluation of left atrial function and mechanical dispersion in breast cancer patients after chemotherapy	5
Prognostic value of global longitudinal strain in hypertrophic cardiomyopathy: A systematic review and meta‐analysis	5
Cognitive behavioral therapy delivered via digital mobile application for the treatment of type 2 diabetes: Rationale, design, and baseline characteristics of a randomized, controlled trial	4
Association of psychosocial factors with all‐cause hospitalizations in patients with atrial fibrillation	4
The role of coronary artery calcium in allocating pharmacotherapy for primary prevention of cardiovascular disease: The ABCs of CAC	4
Cardiac troponin I predicts clinical outcome of patients with cancer at emergency department	4
The characteristics and efficacy of catheter ablation of focal atrial tachycardia arising from an epicardial site	4
Prevalence and adverse outcomes of frailty in older patients with acute myocardial infarction after percutaneous coronary interventions: A systematic review and meta‐analysis	4
Remdesivir therapy associated with Bradycardia in SARS‐CoV2	4
6‐year change in high sensitivity cardiac troponin T and the risk of atrial fibrillation in the Atherosclerosis Risk in Communities cohort	4
The effect of left atrial remodeling after cryoballoon ablation and radiofrequency ablation for paroxysmal atrial fibrillation	4
Benefit and risk of adding rivaroxaban in patients with coronary artery disease: A systematic review and meta‐analysis	4
Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL‐AF registry	4
Pragmatic randomized trial assessing the impact of digital health technology on quality of life in patients with heart failure: Design, rationale and implementation	4
Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy	4
Impact of the “atherosclerotic pabulum” on in‐hospital mortality for SARS‐CoV‐2 infection. Is calcium score able to identify at‐risk patients?	4
Prospective evaluation of lipid management following acute coronary syndrome in non‐Western countries	4
The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population	4
Application of transesophageal echocardiography for localization in totally implantable venous access port implantation through subclavian approach in children	4
The association between systemic inflammatory response index and in‐hospital mortality in patients with infective endocarditis	4
Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury	4
Performance of pulse palpation compared to one‐lead ECG in atrial fibrillation screening	4
Association between exposure to Efavirenz and substrates of dysrhythmia in HIV‐infected young adults	4
Progressive tricuspid regurgitation and elevated pressure gradient after transvenous permanent pacemaker implantation	4